SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-071527
Filing Date
2024-06-10
Accepted
2024-06-10 19:35:36
Documents
1
Period of Report
2024-06-06

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3927
  Complete submission text file 0000950170-24-071527.txt   5399
Mailing Address C/O ESPERION THERAPEUTICS, INC. 46701 COMMERCE CENTER DRIVE PLYMOUTH MI 48170
Business Address
Ignelzi Troy A. (Reporting) CIK: 0001579829 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42121 | Film No.: 241034321

Mailing Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 401 BOSTON MA 02215 857-321-8020
Rapport Therapeutics, Inc. (Issuer) CIK: 0002012593 (see all company filings)

IRS No.: 880724208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)